6. Parkinson disease Clinical trials / Disease details

Clinical trials : 2,307 /  Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199

  
2 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT03968133
(ClinicalTrials.gov)		December 10, 202028/5/2019Treating Anxiety in Parkinson's Disease With a Multi-Strain ProbioticTreating Anxiety in Parkinson's Disease With a Multi-Strain Probiotic - a Randomized, Placebo-controlled TrialParkinson Disease;AnxietyDietary Supplement: Probiotic;Dietary Supplement: PlaceboUniversity of British ColumbiaThe W. Garfield Weston FoundationRecruiting40 Years80 YearsAll72Phase 2Canada
2NCT05146921
(ClinicalTrials.gov)		July 4, 20192/11/2021Gut Health and Probiotics in Parkinson's (SymPD)Gut Health and Probiotics in Parkinson's (SymPD)Parkinson DiseaseDietary Supplement: Multi-strain probiotic;Other: PlaceboKing's College Hospital NHS TrustKing's College LondonActive, not recruiting18 YearsN/AAll60N/AUnited Kingdom